Search Results - "KIDD, Mark"
-
1
The Epidemiology of Gastroenteropancreatic Neuroendocrine Tumors
Published in Endocrinology and metabolism clinics of North America (01-03-2011)“…In this article, updated analyses of the National Cancer Institute Surveillance, Epidemiology and End Results (SEER) registry (1973–2007) are presented and…”
Get full text
Journal Article -
2
The identification of gut neuroendocrine tumor disease by multiple synchronous transcript analysis in blood
Published in PloS one (15-05-2013)“…Gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs) are increasing in both incidence and prevalence. A delay in correct diagnosis is common for these…”
Get full text
Journal Article -
3
Recommendations for management of patients with neuroendocrine liver metastases
Published in The lancet oncology (2014)“…Summary Many management strategies exist for neuroendocrine liver metastases. These strategies range from surgery to ablation with various interventional…”
Get full text
Journal Article -
4
PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest
Published in European journal of nuclear medicine and molecular imaging (01-04-2020)“…Purpose Peptide receptor radionuclide therapy (PRRT) is effective for metastatic/inoperable neuroendocrine tumors (NETs). Imaging response assessment is…”
Get full text
Journal Article -
5
NET Blood Transcript Analysis Defines the Crossing of the Clinical Rubicon: When Stable Disease Becomes Progressive
Published in Neuroendocrinology (01-01-2017)“…A key issue in gastroenteropancreatic neuroendocrine tumors (GEP-NETs) is early identification and prediction of disease progression. Clinical evaluation and…”
Get more information
Journal Article -
6
Bronchopulmonary neuroendocrine tumors
Published in Cancer (01-07-2008)“…Bronchopulmonary neuroendocrine tumors (BP‐NETs) comprise ≈20% of all lung cancers and represent a spectrum of tumors arising from neuroendocrine cells of the…”
Get full text
Journal Article -
7
Case-Control Study of Aspirin Use and Risk of Pancreatic Cancer
Published in Cancer epidemiology, biomarkers & prevention (01-07-2014)“…Pancreas-cancer prognosis is dismal, with 5-year survival less than 5%. Significant relationships between aspirin use and decreased pancreas-cancer incidence…”
Get full text
Journal Article -
8
Aspirin Use and Reduced Risk of Pancreatic Cancer
Published in Cancer epidemiology, biomarkers & prevention (01-01-2017)“…Few options besides the avoidance of smoking and obesity are available to prevent pancreatic cancer. The association between aspirin use and risk of pancreatic…”
Get full text
Journal Article -
9
The status of neuroendocrine tumor imaging: from darkness to light?
Published in Neuroendocrinology (01-01-2015)“…Diagnostic imaging plays a pivotal role in the diagnosis, staging, treatment selection and follow-up for neuroendocrine tumors. The available diagnostic…”
Get more information
Journal Article -
10
Chromogranin A—Biological Function and Clinical Utility in Neuro Endocrine Tumor Disease
Published in Annals of surgical oncology (01-09-2010)“…Background Neuroendocrine tumors (NETs) are a form of cancer that differ from other neoplasia in that they synthesize, store, and secrete peptides, e.g.,…”
Get full text
Journal Article -
11
A multianalyte PCR blood test outperforms single analyte ELISAs (chromogranin A, pancreastatin, neurokinin A) for neuroendocrine tumor detection
Published in Endocrine-related cancer (01-08-2014)“…A critical requirement in neuroendocrine tumor (NET) management is a sensitive, specific and reproducible blood biomarker test. We evaluated a PCR-based 51…”
Get full text
Journal Article -
12
A 5‐decade analysis of 13,715 carcinoid tumors
Published in Cancer (15-02-2003)“…BACKGROUND Carcinoid tumors represent an unusual and complex disease spectrum with protean clinical manifestations. This compilation of several large United…”
Get full text
Journal Article -
13
Detectable Symptomatology Preceding the Diagnosis of Pancreatic Cancer and Absolute Risk of Pancreatic Cancer Diagnosis
Published in American journal of epidemiology (01-07-2015)“…The survival duration for pancreatic cancer is short. Given its low lifetime risk (1.5%), established factors for the disease have insufficient specificity to…”
Get full text
Journal Article -
14
Early Identification of Residual Disease After Neuroendocrine Tumor Resection Using a Liquid Biopsy Multigenomic mRNA Signature (NETest)
Published in Annals of surgical oncology (01-11-2021)“…Introduction Surgery is the only cure for neuroendocrine tumors (NETs), with R0 resection being critical for successful tumor removal. Early detection of…”
Get full text
Journal Article -
15
The Clinical Relevance of Chromogranin A as a Biomarker for Gastroenteropancreatic Neuroendocrine Tumors
Published in Endocrinology and metabolism clinics of North America (01-03-2011)“…Chromogranin A, although it exhibits limitations, is currently the most useful general tumor biomarker available for use in the diagnosis and management of…”
Get full text
Journal Article -
16
Radiolabeled Somatostatin Analogue Therapy Of Gastroenteropancreatic Cancer
Published in Seminars in nuclear medicine (01-05-2016)“…Peptide receptor radionuclide therapy (PRRT) has been utilized for more than two decades and has been accepted as an effective therapeutic modality in the…”
Get full text
Journal Article -
17
Neuroendocrine tumor disease: an evolving landscape
Published in Endocrine-related cancer (01-10-2012)“…Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) represent a heterogenous group of tumors arising from a variety of neuroendocrine cell types. The…”
Get full text
Journal Article -
18
Helicobacter pylori Seropositivities and Risk of Pancreatic Carcinoma
Published in Cancer epidemiology, biomarkers & prevention (01-01-2014)“…Pathophysiologic actions of Helicobacter pylori colonization on gastric acidity have been hypothesized to modulate the effect of pancreatic carcinogens,…”
Get full text
Journal Article -
19
Current Status of Gastrointestinal Carcinoids
Published in Gastroenterology (New York, N.Y. 1943) (01-05-2005)“…Gastrointestinal (GI) carcinoids are ill-understood, enigmatic malignancies, which, although slow growing compared with adenocarcinomas, can behave…”
Get full text
Journal Article -
20
An Assessment of Circulating Chromogranin A as a Biomarker of Bronchopulmonary Neuroendocrine Neoplasia: A Systematic Review and Meta-Analysis
Published in Neuroendocrinology (01-02-2020)“…Management of bronchopulmonary neuroendocrine neoplasia (NEN; pulmonary carcinoids [PCs], small-cell lung cancer [SCLC], and large cell neuroendocrine…”
Get more information
Journal Article